Kindstar Globalgene Technology, Inc. executed an on-market share repurchase on 7 July 2026, buying back 4,500 ordinary shares at HK$0.97 each. The transaction cost totalled HK$4,365.

Following the repurchase: • Issued shares (excluding treasury shares) declined marginally by 0.00044 % to 1,033.84 million. • Treasury shares rose to 7.49 million. • Total issued shares remained unchanged at 1,041.33 million, as the repurchased shares are being held in treasury rather than cancelled.

The buyback formed part of the mandate approved on 5 June 2026, which authorises repurchases of up to 103.43 million shares. Cumulative purchases under this mandate now stand at 427,500 shares, representing 0.04133 % of the company’s issued share capital on the mandate date.

Under Hong Kong Stock Exchange rules, Kindstar Global is restricted from issuing new shares or disposing of treasury shares until 6 August 2026.